Li-Peng Liu1, Kang Cheng2, Ming-An Ning3, Hong-Hong Li4, Hai-Chang Wang1, Fei Li1, Shu-Ying Chen5, Fa-Lin Qu6, Wen-Yi Guo7. 1. Department of Cardiovascular Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. 2. Department of Cardiovascular Medicine, Third Hospital of Xi'an, 710082, China. 3. Department of Cardiovascular Medicine, First Hospital of Xi'an, 710002, China. 4. Department of Internal Medicine, 61906 Force, Langfang 065001, China. 5. Department of Cardiology, The 323th Hospital of PLA, Xi'an 710054, China. 6. Department of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an 710032, China. 7. Department of Cardiovascular Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. Electronic address: wenyi_guo@126.com.
Abstract
BACKGROUND AND AIMS: Leukocyte mitochondrial DNA (mtDNA) content reflects the oxidant-induced cell damage, which has been observed in a wide range of cardiovascular diseases. However, whether it correlates with coronary heart disease (CHD), which closely relates to oxidative stress, has never been elucidated before. The aim of this study was to explore association between mtDNA content and the presence and severity of CHD. METHODS: The study population consisted of 400 individuals (290 with CHD and 110 controls). A quantitative real-time PCR was performed to measure the relative content of mtDNA in peripheral blood cells (PBCs). Gensini score was used to evaluate the severity of coronary stenotic lesions. An unconditional multivariate logistic regression was developed to estimate the association between CHD risk and mtDNA content by using odds ratio (OR). This study is registered with ClinicalTrials.gov, number NCT02500823. RESULTS: CHD patients, compared to controls, had lower mtDNA content (median, 0.78 vs. 0.83, p < 0.001), and mtDNA levels significantly decreased following an increasing Gensini score (p < 0.001). By using the first (highest mtDNA content) quartile of mtDNA content of controls as reference, the adjusted ORs (95% CIs) for individuals in the second, third and highest quartile of mtDNA content were 1.78 (95% CI, 1.15-3.51), 2.21 (95% CI, 1.65-3.74) and 4.83 (95% CI, 2.67-8.64), respectively (p for trend <0.001). CONCLUSIONS: These preliminary results suggest that expression of mtDNA may be associated with atherogenesis. The level of peripheral blood mtDNA in predicting the severity of coronary atherosclerosis may have a relatively certain value.
BACKGROUND AND AIMS: Leukocyte mitochondrial DNA (mtDNA) content reflects the oxidant-induced cell damage, which has been observed in a wide range of cardiovascular diseases. However, whether it correlates with coronary heart disease (CHD), which closely relates to oxidative stress, has never been elucidated before. The aim of this study was to explore association between mtDNA content and the presence and severity of CHD. METHODS: The study population consisted of 400 individuals (290 with CHD and 110 controls). A quantitative real-time PCR was performed to measure the relative content of mtDNA in peripheral blood cells (PBCs). Gensini score was used to evaluate the severity of coronary stenotic lesions. An unconditional multivariate logistic regression was developed to estimate the association between CHD risk and mtDNA content by using odds ratio (OR). This study is registered with ClinicalTrials.gov, number NCT02500823. RESULTS: CHD patients, compared to controls, had lower mtDNA content (median, 0.78 vs. 0.83, p < 0.001), and mtDNA levels significantly decreased following an increasing Gensini score (p < 0.001). By using the first (highest mtDNA content) quartile of mtDNA content of controls as reference, the adjusted ORs (95% CIs) for individuals in the second, third and highest quartile of mtDNA content were 1.78 (95% CI, 1.15-3.51), 2.21 (95% CI, 1.65-3.74) and 4.83 (95% CI, 2.67-8.64), respectively (p for trend <0.001). CONCLUSIONS: These preliminary results suggest that expression of mtDNA may be associated with atherogenesis. The level of peripheral blood mtDNA in predicting the severity of coronary atherosclerosis may have a relatively certain value.
Authors: Foram N Ashar; Yiyi Zhang; Ryan J Longchamps; John Lane; Anna Moes; Megan L Grove; Josyf C Mychaleckyj; Kent D Taylor; Josef Coresh; Jerome I Rotter; Eric Boerwinkle; Nathan Pankratz; Eliseo Guallar; Dan E Arking Journal: JAMA Cardiol Date: 2017-11-01 Impact factor: 14.676
Authors: Christina A Castellani; Ryan J Longchamps; Jing Sun; Eliseo Guallar; Dan E Arking Journal: Mitochondrion Date: 2020-06-13 Impact factor: 4.160
Authors: Liron Ganel; Lei Chen; Ryan Christ; Jagadish Vangipurapu; Erica Young; Indraniel Das; Krishna Kanchi; David Larson; Allison Regier; Haley Abel; Chul Joo Kang; Alexandra Scott; Aki Havulinna; Charleston W K Chiang; Susan Service; Nelson Freimer; Aarno Palotie; Samuli Ripatti; Johanna Kuusisto; Michael Boehnke; Markku Laakso; Adam Locke; Nathan O Stitziel; Ira M Hall Journal: Hum Genomics Date: 2021-06-07 Impact factor: 6.481
Authors: Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; José A Sánchez-Alcázar Journal: Biomedicines Date: 2021-03-05